Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Auditor change
|
|
iBio, Inc. (IBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/13/2021 |
4/A
| Isett Thomas Francis 3rd (CEO and Executive Chairman) has filed a Form 4 on iBio, Inc. |
| 10/28/2020 |
4/A
| Kay Robert (Director) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 400,000 options
@ $0 |
|
| 04/24/2020 |
4/A
| Isett Thomas Francis 3rd (CEO and Executive Chairman) has filed a Form 4 on iBio, Inc.|
Txns:
| Granted 975,000 options to buy
@ $0.8953, valued at
$872.9k
|
|
| 01/31/2020 |
4/A
| DART KENNETH BRYAN (10% Owner) has filed a Form 4 on iBio, Inc.|
Txns:
| Acquired 1 shares
@ $0 |
|
| 05/31/2019 |
4/A
| Kay Robert (Executive Chairman and CEO) has filed a Form 4 on iBio, Inc.|
Txns:
| Disposed/sold 25,000 options to buy
@ $6.6, valued at
$165k
Granted 18,750 options to buy
@ $0.93, valued at
$17.4k
Disposed/sold 30,000 options to buy
@ $17.3, valued at
$519k
Granted 22,500 options to buy
@ $0.93, valued at
$20.9k
Disposed/sold 50,000 options to buy
@ $30.7, valued at
$1.5M
Granted 37,500 options to buy
@ $0.93, valued at
$34.9k
Disposed/sold 30,000 options to buy
@ $19.6, valued at
$588k
Disposed/sold 30,000 options to buy
@ $11, valued at
$330k
Disposed/sold 30,000 options to buy
@ $5, valued at
$150k
Disposed/sold 60,000 options to buy
@ $10, valued at
$600k
Granted 45,000 options to buy
@ $0.93, valued at
$41.9k
|
|
| 02/04/2014 |
4/A
| DESANTIS CARL (10% Owner) has filed a Form 4 on iBio, Inc. |
| 02/04/2014 |
4/A
| DESANTIS CARL (10% Owner) has filed a Form 4 on iBio, Inc. |
| 10/17/2013 |
4/A
| Eastern Capital LTD (10% Owner) has filed a Form 4 on iBio, Inc. |
| 03/28/2012 |
4/A
| MCKEY JOHN D JR (Director) has filed a Form 4 on iBio, Inc. |
| 03/28/2012 |
4/A
| MCKEY JOHN D JR (Director) has filed a Form 4 on iBio, Inc. |
| 03/28/2012 |
4/A
| MCKEY JOHN D JR (Director) has filed a Form 4 on iBio, Inc. |
|
|